Stock Trading Canary

Data as of 5 Nov 2026

← United States · 中文

COMPANY RESEARCH

Rapport Therapeutics, Inc.

RAPP · United States · Healthcare

Insider Signal

Snapshot: 05 Nov 2026 · 180-day research window

Data quality under review
Insider Signal
84.7 / 100
Research score, not a buy recommendation
Reported buyers
7
180-day scoring window
Net purchases
7.82m USD
180 days · purchases less sales
Latest disclosure
2026-11-03
Publication date
What stands out
  • 7 reported buyers participated in qualifying purchases during the last 180 days.
  • HEALY JAMES accounts for 92% of comparable reported purchase value; buyer breadth and value are different measures.
  • The share price fell 38.3% over 180 days; inspect disclosure dates before interpreting the purchases.

Price vs insider buying

RAPP · USD

● Purchase × Sale ◇ Public disclosure ▥ 15-day cluster ·

Circles and crosses mark trade dates; diamonds below the axis mark later public disclosures. The trade became public on its disclosure date. Prices are nearest-session closes, not insider execution prices. Marker sizes are not compared when values or currencies differ.

BULL VS BEAR

Two readings of this buying

The same filings, read two ways. Each line is a fact stored for this company with the number behind it, and appears only when that number crosses a fixed threshold. Neither side is a forecast and no winner is declared.

Where the evidence comes from

The two kinds of evidence disagree: the purchases themselves carry bull lines (several insiders together, more buyers than usual here, large purchases, bought in the last two weeks), while share price and trading argue against (price down over six months, price trails its sector); short sellers argue against (high short interest). No data is held for: company results, company actions.

  • The insider purchases themselvesBullseveral insiders together, more buyers than usual here, large purchases, bought in the last two weeks Bearvalue concentrated in one buyer, insiders also sold1 checked, under the threshold · 3 missing
  • Share price and tradingBearprice down over six months, price trails its sector
  • Short sellersBearhigh short interest1 checked, under the threshold
  • Company results2 missing
  • Company actionsno data held

Bull case · the buying is informative

  • 7 insiders bought within 15 days (2026-10-21 to 2026-10-28). Several people reaching the same decision at the same time is hard to put down to one person's circumstances.
  • No insider bought in the 180 days before this window; 7 have bought in it. The buying is new for this company, not a habit.
  • Insiders committed a net $7.8M of their own money in 180 days.
  • The latest purchase is 8 days old (2026-10-28). The buying is current, not left over from an earlier quarter.

Bear case · discount it

  • HEALY JAMES accounts for 92% of the value bought. The other 6 buyers add names more than money.
  • Insiders also sold $14.2M in the same 180 days, 65% of the amount bought.
  • Share price and tradingThe share price is down 41% over six months (three months −48%, one month −23%) and stands 55% below its 52-week high. Insiders have bought into a fall the market has not reversed.
  • Share price and tradingOver three months the share price changed −48% and the median of 220 Healthcare companies changed −18%: 30 points behind. The market has marked this company down against its own sector.
  • Short sellersFINRA short interest on 2026-10-15 was 3,051,500 shares, 11.8 days of average trading volume and 6.4% of the 47,978,286 shares outstanding, down 4.5% from the previous report: other investors hold a sizeable position the opposite way.

Evidence still missing

  • No buyer here has 5 or more completed earlier purchases on record, so there is no track record to weigh.
  • The company's market value is not captured, so the purchases cannot be stated as a share of the business or of its trading volume.
  • No earnings, margin or cash-flow figures are captured for this company. The latest annual and interim reports are where to check whether the business is improving or deteriorating.
  • The 10b5-1 box of these Form 4 filings has not been read, so whether the purchases followed a pre-arranged plan is not known.
  • Form 4 states the shares held after each trade. This site reads that from the SEC's quarterly data, which is published after a quarter ends, so it does not have it yet for these filings. Whether a purchase added 1% to a personal stake or doubled it is in the filing, not on this page.
Checked and under the threshold: 2
  • BearOver the last 5 trading days to 2026-11-05, 63% of this stock's off-exchange volume was sold short; over the 60 days before, 57%. The market's median is 47%. This is trading volume, not a position: a market maker who sells short and covers the same day is counted, so about half of all volume is short on an ordinary day. It is shown for comparison and counts for neither side.
  • BearNo insider filing in the last 180 days opened a hedge on this stock.

Both columns arrange stored facts only. They do not change the insider score or the ranking and are not investment advice.

Who is trading?

Named filings in 180 days. Purchase values are summed only when complete and in one currency.

InsiderTransaction activityPurchase valueLatest tradeDetails
HEALY JAMESBoard member4 buy · 0 sell20.36m USD2026-10-28
View transactions · 4
Trade dateDisclosureTypeSharesPriceCurrencyReported valueSource
2026-10-282026-10-30Open market purchase95238021.0USD19999980.0Source ↗
2026-10-282026-10-30Open market purchase639521.0USD134295.0Source ↗
2026-10-282026-10-30Open market purchase377221.0USD79212.0Source ↗
2026-10-282026-10-30Open market purchase693321.0USD145593.0Source ↗
PAUL STEVEN MBoard member1 buy · 0 sell974.3k USD2026-10-22
View transactions · 1
Trade dateDisclosureTypeSharesPriceCurrencyReported valueSource
2026-10-222026-10-22Open market purchase3571427.28USD974277.92Source ↗
MARAGANORE JOHNBoard member2 buy · 0 sell248.9k USD2026-10-22
View transactions · 2
Trade dateDisclosureTypeSharesPriceCurrencyReported valueSource
2026-10-222026-10-22Open market purchase823926.3799USD217343.9961Source ↗
2026-10-222026-10-22Open market purchase117226.9173USD31547.0756Source ↗
Ignelzi Troy A.CFO1 buy · 0 sell143.6k USD2026-10-21
View transactions · 1
Trade dateDisclosureTypeSharesPriceCurrencyReported valueSource
2026-10-212026-10-21Open market purchase550026.1USD143550.0Source ↗
Young Wendy B.Board member1 buy · 0 sell100.0k USD2026-10-22
View transactions · 1
Trade dateDisclosureTypeSharesPriceCurrencyReported valueSource
2026-10-222026-10-22Open market purchase378926.39USD99991.71Source ↗
Silva Paul MBoard member1 buy · 0 sell99.6k USD2026-10-22
View transactions · 1
Trade dateDisclosureTypeSharesPriceCurrencyReported valueSource
2026-10-222026-10-22Open market purchase368027.075USD99636.0Source ↗
Sanchez RamiroBoard member1 buy · 0 sell98.5k USD2026-10-23
View transactions · 1
Trade dateDisclosureTypeSharesPriceCurrencyReported valueSource
2026-10-232026-10-23Open market purchase360027.3549USD98477.64Source ↗
Ceesay AbrahamCEO / chair0 buy · 20 sellNo purchases2026-10-21
View transactions · 20
Trade dateDisclosureTypeSharesPriceCurrencyReported valueSource
2026-10-212026-10-23Open market sale221029.1618USD64447.578Source ↗
2026-10-072026-10-08Open market sale114730.66USD35167.02Source ↗
2026-10-062026-10-08Open market sale337532.0314USD108105.97499999999Source ↗
2026-09-232026-09-24Open market sale1952.039.05USD76225.59999999999Source ↗
2026-09-232026-09-24Open market sale43.041.05USD1765.1499999999999Source ↗
2026-09-232026-09-24Open market sale215.039.86USD8569.9Source ↗
2026-09-082026-09-09Open market sale1069.046.01USD49184.689999999995Source ↗
2026-09-082026-09-09Open market sale7141.045.56USD325343.96Source ↗
2026-08-252026-08-26Open market sale18921.049.57USD937913.97Source ↗
2026-08-112026-08-12Open market sale3664.046.9USD171841.6Source ↗
2026-08-112026-08-12Open market sale19500.048.04USD936780.0Source ↗
2026-08-112026-08-12Open market sale5794.048.62USD281704.27999999997Source ↗
2026-08-102026-08-12Open market sale14171.045.97USD651440.87Source ↗
2026-08-102026-08-12Open market sale8370.046.75USD391297.5Source ↗
2026-07-272026-07-29Open market sale2203.042.11USD92768.33Source ↗
2026-07-272026-07-29Open market sale7.042.74USD299.18Source ↗
2026-07-142026-07-15Open market sale2729.040.57USD110715.53Source ↗
2026-07-142026-07-15Open market sale5481.039.72USD217705.32Source ↗
2026-06-292026-07-01Open market sale876.040.34USD35337.840000000004Source ↗
2026-06-292026-07-01Open market sale7344.039.77USD292070.88Source ↗
Gault CherylExecutive0 buy · 6 sellNo purchases2026-09-30
View transactions · 6
Trade dateDisclosureTypeSharesPriceCurrencyReported valueSource
2026-09-302026-10-01Open market sale792533.0364USD261813.47Source ↗
2026-09-302026-10-01Open market sale207533.7556USD70042.87Source ↗
2026-06-302026-07-01Open market sale1000.043.15USD43150.0Source ↗
2026-06-302026-07-01Open market sale3308.042.17USD139498.36000000002Source ↗
2026-06-302026-07-01Open market sale1900.040.09USD76171.0Source ↗
2026-06-302026-07-01Open market sale3792.041.39USD156950.88Source ↗
TRV GP V, LLC; TRV GP VI, LLC; Third Rock Ventures GP V, LP; Third Rock Ventures GP VI, L.P.; Third Rock Ventures V, L.P.; Third Rock Ventures VI, L.P.TenPercentOwner0 buy · 2 sellNo purchases2026-10-30
View transactions · 4
Trade dateDisclosureTypeSharesPriceCurrencyReported valueSource
2026-10-302026-11-03Grant or award23809521.0USD4999995.0Source ↗
2026-10-302026-11-03Grant or award119047621.0USD24999996.0Source ↗
2026-05-262026-05-28Open market sale18572.040.05USD743808.6Source ↗
2026-05-112026-05-13Open market sale133618.040.24USD5376788.32Source ↗
Yeleswaram KrishnaswamyExecutive0 buy · 4 sellNo purchases2026-08-25
View transactions · 4
Trade dateDisclosureTypeSharesPriceCurrencyReported valueSource
2026-08-252026-08-26Open market sale16201.051.06USD827223.06Source ↗
2026-08-252026-08-26Open market sale20799.050.31USD1046397.6900000001Source ↗
2026-08-242026-08-26Open market sale13160.050.0USD658000.0Source ↗
2026-08-192026-08-20Open market sale404.049.9USD20159.6Source ↗

INSIDER SIGNAL

Score breakdown:84.7 / 100

7 insiders · 7 purchase events · $7.82m net purchases

US #21 · United States #21

WHY THIS SIGNAL?

Score anatomy

Each bar is that part's points in the score; the five parts add up to the score.

Number of buyers+35.0 / 35

How many different insiders bought within 15 days

Amount bought+22.4 / 25

The value bought, net of any insider sales

Buyers' roles+15.0 / 20

Lower in the company scores higher: in the backtest, purchases by the most senior insiders did worse

How recent+8.8 / 10

How long ago the latest purchase took place

Buying against selling+3.5 / 10

Lower when insiders also sold

What is holding the score back?

  • ⚠ Insiders also sold, which lowers this part
  • ✓ Many buyers · 4 or more different insiders
  • ✓ Buyers' roles add a lot · the buyers are below the top of the company
  • ✓ Recent buying · latest purchase 2026-10-28

Buyers' roles follow the US order of roles: CEOs, chairs and 10% owners score lowest.

BUYING PROFILE

7 events · 7 insiders · 180d

Cluster 100%Repeat 0%Independent 0%Large 0%

Percentages are mutually exclusive and sum to 100%.

Buying concentration

92%

Largest buyer:HEALY JAMES · 20.36m USD
Purchases counted, before sales:22.02m USD

The amount at the top of the page is purchases minus sales; this one counts purchases only, in the filing currency, so the two can differ. The score counts how many people bought; this shows separately who bought the most.

This is a ranking under the current US screening rules—not a probability of gain, return forecast, or buy recommendation.

Key purchase quotes (filing currency)

FilerPrice per unitTrade date
HEALY JAMES21 USDOct 28, 2026
Sanchez Ramiro27.3549 USDOct 23, 2026
PAUL STEVEN M27.28 USDOct 22, 2026
Model details

Cluster breakdown (does not change the score)

15-day buyer breadth (count)
7 distinct reported filers
Peak time window
2026-10-21 to 2026-10-28
Current breadth input
1.000 (capped at 4+ buyers)
Buyer independence
Not yet measured; related-party fields are not cross-market comparable

What the filings show

Filing and data quality

These checks are auditable context; they do not change the rank or score.

Identity match
REVIEW
Ticker / ISIN
Ticker or ISIN missing
Filing source links
89 / 89
Median disclosure lag
1 days
Latest disclosure age
2 days at snapshot
Corrections / revisions
0
Score-factor detail
Saved

Insider timeline

7 insiders bought within 8 days, 21 Oct to 28 Oct: 6 Board member, 1 CFO. The share closed at 25.06 on the first of those days and at 23.72 most recently (−5.3%). That week 84 companies across United States disclosed insider purchases, an ordinary week (19 of the last 26).

Several insiders within 15 days: 2026-10-21 – 2026-10-28Ceesay AbrahamCeesay AbrahamChief Executive OfficerCEO / chairGault CherylGault CherylChief Operating OfficerExecutiveYeleswaram KrishnaswamyYeleswaram KrishnaswamyChief Development OfficerExecutiveIgnelzi Troy A.Ignelzi Troy A.Chief Financial OfficerCFOMARAGANORE JOHNMARAGANORE JOHNDirectorBoard memberPAUL STEVEN MPAUL STEVEN MDirectorBoard memberSilva Paul MSilva Paul MDirectorBoard memberYoung Wendy B.Young Wendy B.DirectorBoard memberSanchez RamiroSanchez RamiroDirectorBoard memberHEALY JAMESHEALY JAMESDirectorBoard member2026-06-29 · Ceesay Abraham · sale · 327,409 USD2026-06-30 · Gault Cheryl · sale · 415,770 USD2026-07-14 · Ceesay Abraham · sale · 328,421 USD2026-07-27 · Ceesay Abraham · sale · 93,068 USD2026-08-10 · Ceesay Abraham · sale · 1,042,738 USD2026-08-11 · Ceesay Abraham · sale · 1,390,326 USD2026-08-19 · Yeleswaram Krishnaswamy · sale · 20,160 USD2026-08-24 · Yeleswaram Krishnaswamy · sale · 658,000 USD2026-08-25 · Ceesay Abraham · sale · 937,914 USD2026-08-25 · Yeleswaram Krishnaswamy · sale · 1,873,621 USD2026-09-08 · Ceesay Abraham · sale · 374,529 USD2026-09-23 · Ceesay Abraham · sale · 86,561 USD2026-09-30 · Gault Cheryl · sale · 331,856 USD2026-10-06 · Ceesay Abraham · sale · 108,106 USD2026-10-07 · Ceesay Abraham · sale · 35,167 USD2026-10-21 · Ceesay Abraham · sale · 64,448 USD2026-10-21 · Ignelzi Troy A. · purchase · 143,550 USD2026-10-22 · MARAGANORE JOHN · purchase · 248,891 USD2026-10-22 · PAUL STEVEN M · purchase · 974,278 USD2026-10-22 · Silva Paul M · purchase · 99,636 USD2026-10-22 · Young Wendy B. · purchase · 99,992 USD2026-10-23 · Sanchez Ramiro · purchase · 98,478 USD2026-10-28 · HEALY JAMES · purchase · 20,359,080 USD2026-05-11 to 2026-05-17: 232 companies2026-05-18 to 2026-05-24: 259 companies2026-05-25 to 2026-05-31: 171 companies2026-06-01 to 2026-06-07: 192 companies2026-06-08 to 2026-06-14: 172 companies2026-06-15 to 2026-06-21: 163 companies2026-06-22 to 2026-06-28: 108 companies2026-06-29 to 2026-07-05: 93 companies2026-07-06 to 2026-07-12: 80 companies2026-07-13 to 2026-07-19: 79 companies2026-07-20 to 2026-07-26: 70 companies2026-07-27 to 2026-08-02: 77 companies2026-08-03 to 2026-08-09: 131 companies2026-08-10 to 2026-08-16: 200 companies2026-08-17 to 2026-08-23: 218 companies2026-08-24 to 2026-08-30: 184 companies2026-08-31 to 2026-09-06: 175 companies2026-09-07 to 2026-09-13: 139 companies2026-09-14 to 2026-09-20: 186 companies2026-09-21 to 2026-09-27: 134 companies2026-09-28 to 2026-10-04: 130 companies2026-10-05 to 2026-10-11: 73 companies2026-10-12 to 2026-10-18: 72 companies2026-10-19 to 2026-10-25: 84 companies2026-10-26 to 2026-11-01: 107 companies2026-11-02 to 2026-11-08: 63 companiesCompanies disclosing purchases, per weekJunJulAugSepOctNov

Tap an item for what it means.

●A purchase: the bigger the dot, the more was bought

Each dot is one insider's purchases on one day. The dot's area follows the amount: the largest purchase here gets the largest dot. Hold the pointer over a dot to see the date and the amount.

×A sale

A cross is one insider's sales on one day. People sell to pay tax, to cash in share awards or to hold less of one company, so a sale says less than a purchase does. When someone bought and sold on the same day, the cross sits beside the dot. The totals are under “Purchases against sales” below.

▮Purple band: several insiders bought within 15 days

The band marks the stretch with the most different buyers: at most 15 days long and at least two people. Here it is 21 Oct – 28 Oct, with 7 insiders. Only the strongest stretch is marked. Several people deciding the same thing is harder to explain by one person's private reasons, but insiders often buy together just after a closed period ends, so compare it with the grey weekly bars.

Blue line: this share's price, −38.3% over these six months

The closing price of each day, from 38.43 on 2026-05-11 to 23.72 on 2026-11-05. The line has no scale; read it for high and low: a dot on a low stretch was bought cheaply, a dot on a high stretch was not.

Dashed line: the typical stock on the same exchange, −9.6%

Taken from the 1610 other stocks on the same exchange that this site holds prices for. Each is measured from the first day of the window, and every day the middle one is drawn. It starts where the blue line starts, so the gap between the two is the difference: this share −38.3%, the typical one −9.6%, 28.7 points behind. It is not an index and not a comparison within one industry.

▂Grey bars: companies across United States disclosing purchases each week

A taller bar is a week in which more companies disclosed insider purchases. The purple bar is the week of the band above: 84 companies, number 19 of the last 26 weeks. If that week was a peak anyway, buying together is less special than it looks.

1 more insiders traded in the window and are not drawn.

This company: insiders buying per month, last 12 months

Dec
Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
7Oct
Nov

Darker bars are inside the 180-day window above.

Who traded

InsiderRolePurchasesSalesBoughtFirst purchaseShare price since
Ceesay AbrahamCEO / chair—11———
Gault CherylExecutive—2———
Yeleswaram KrishnaswamyExecutive—3———
Ignelzi Troy A.CFO1—143.6k USD2026-10-21−5.3%
MARAGANORE JOHNBoard member1—248.9k USD2026-10-22−10.6%
PAUL STEVEN MBoard member1—974.3k USD2026-10-22−10.6%
Silva Paul MBoard member1—99.6k USD2026-10-22−10.6%
Young Wendy B.Board member1—100.0k USD2026-10-22−10.6%
Sanchez RamiroBoard member1—98.5k USD2026-10-23−8.5%
HEALY JAMESBoard member1—20.4M USD2026-10-28+5.4%
TRV GP V, LLC; TRV GP VI, LLC; Third Rock Ventures GP V, LP; Third Rock Ventures GP VI, L.P.; Third Rock Ventures V, L.P.; Third Rock Ventures VI, L.P.Associated person—2———

Purchases against sales

61%purchases
Purchases61%22.0M USD · 11 line(s) · 7 insider(s)
Sales39%14.2M USD · 32 line(s) · 4 insider(s)

Shares of the reported value of insider transactions in the 180-day window. Sales include disposals for tax, at option exercise or under a pre-set plan, which say little about an insider's view. The split describes what was disclosed; it is not a signal.

Insiders' buying price vs the latest close

Insiders paid 21.36 USD a share on average (11 purchase lines, 7 buyers, 2026-10-21 – 2026-10-28). The close on 2026-11-05 was 11.1% above that price.

The latest purchase (2026-10-28) was at 21.00 USD; the close was 13.0% above that price.

Prices paid are weighted by shares and taken from the filings; dividends are not counted. Not scored.

Buying size vs market trading

Complete price and volume history is not yet available.

Market-data coverage: 0 verified sessions · Latest session: — · Ratio status: Unavailable

Traded value is estimated as close × shares traded, in major currency units. Includes disclosed qualifying purchases; disclosures may lag. Contractual or planned acquisitions are not necessarily discretionary. Ratios describe relative trading size, not market participation or score contributions.

Sector context

Healthcare

Buying breadth
4.1% (42 / 1,020 issuers)
Sector rank
#7 / 13

This is sector-level research context. It does not affect the Insider Signal or ranking.

View US sector research →

Insider profile outcomes

Historical performance following insider filings. The company role is translated below each name while preserving the original title.

Events are disclosure-level observations; related disclosures published on the same date may share a return path and may not be statistically independent. This research enrichment does not affect the insider score or ranking.

Young Wendy B.Director2 completed 20D event(s)
PeriodCompleted eventsPrice coverageHit rateMedian excess returnAverage excess returnWorst excess return
5D3Small sample100.0% (3/3)33.3% (1/3)-1.6%+2.1%-9.5%
20D2Small sample100.0% (2/2)50.0% (1/2)+1.8%+1.8%-9.3%
60D2Small sample100.0% (2/2)100.0% (2/2)+20.2%+20.2%+17.8%
120D2Small sample100.0% (2/2)100.0% (2/2)+29.2%+29.2%+23.6%
First purchase in 12M
1/2
Large purchase ≥ $100k
0/3
Cluster buying · 15D
2/3
Buying the dip · ≥20% below prior 52W high
2/2
Routine / opportunistic
Not classifiable
Ignelzi Troy A.Chief Financial Officer1 completed 20D event(s)
PeriodCompleted eventsPrice coverageHit rateMedian excess returnAverage excess returnWorst excess return
5D2Small sample100.0% (2/2)0.0% (0/2)-5.8%-5.8%-10.1%
20D1Small sample100.0% (1/1)0.0% (0/1)-9.3%-9.3%-9.3%
60D1Small sample100.0% (1/1)100.0% (1/1)+17.8%+17.8%+17.8%
120D1Small sample100.0% (1/1)100.0% (1/1)+34.8%+34.8%+34.8%
First purchase in 12M
1/1
Large purchase ≥ $100k
2/2
Cluster buying · 15D
1/2
Buying the dip · ≥20% below prior 52W high
1/1
Routine / opportunistic
Not classifiable
PAUL STEVEN MDirector1 completed 20D event(s)
PeriodCompleted eventsPrice coverageHit rateMedian excess returnAverage excess returnWorst excess return
5D2Small sample100.0% (2/2)50.0% (1/2)-2.5%-2.5%-9.5%
20D1Small sample100.0% (1/1)100.0% (1/1)+5.3%+5.3%+5.3%
60D1Small sample100.0% (1/1)100.0% (1/1)+12.2%+12.2%+12.2%
120D1Small sample100.0% (1/1)100.0% (1/1)+20.3%+20.3%+20.3%
First purchase in 12M
1/1
Large purchase ≥ $100k
2/2
Cluster buying · 15D
2/2
Buying the dip · ≥20% below prior 52W high
2/2
Routine / opportunistic
Not classifiable

Signal outcomes

Calculated from immutable US ranking snapshots; excess return is stock return minus SPY return. Newly saved snapshots remain pending until each forward horizon matures. This never affects the US score.

HorizonStatusResult
5DAwaiting maturity—
20DAwaiting maturity—
60DAwaiting maturity—
120DAwaiting maturity—

Market context

PRICE PERFORMANCE

1M
-23.1%
3M
-47.9%
6M
-40.6%
12M
-11.0%

VOLATILITY & LIQUIDITY

Volatility
119.6%
Beta
—
Avg daily volume
$17.6M
20-session drawdown
-26.6%
60-session drawdown
-57.1%
Latest volume / prior median
0.8×

VALUATION

Market cap
—
P/E
—

FUNDAMENTALS

Revenue
—
Net income
$-111.5M
Operating profit
$-125.1M
Equity
$484.7M
Cash
$52.6M
Debt
—
Operating cash flow
$-87.5M
Free cash flow
$-88.1M
Profit margin
—
ROE
—
Industry
—

Prices to 05 Nov 2026: price cache (yfinance). From OpenBB/yfinance, captured 04 Nov 2026: Net income, Equity, Operating profit, Cash, Operating cash flow, Free cash flow. It does not affect the insider score or rank.

Dividends

No cash dividend in the last five years.

Yahoo Finance: cash dividends by ex-dividend date, the latest close, the payout ratio (dividends ÷ 12-month earnings per share) and announced dates; special dividends included, stock dividends and splits not. Not part of any score.

Insiders and institutions

Insiders, ranking window: $7.8M net bought · buyers: 7 · last 2026-10-28

Holders of more than 5% (SEC Schedules 13D and 13G)

HolderOf the classScheduleAs ofChange
Third Rock Ventures V, L.P.13.10%13G2026-06-30−6.40 pp
Capital International Investors6.10%13G2026-06-30—
Cormorant Asset Management, LP5.56%13G2026-06-30−0.63 pp
BlackRock, Inc. · large asset manager5.03%13G2025-12-31—

Filings in the last 12 months

1 new · 0 raised · 4 cut · 0 fell to 5% or less

As ofHolderScheduleStakeWhat happened
2026-06-30Third Rock Ventures V, L.P.13G19.50% → 13.10%cut
2026-06-30Cormorant Asset Management, LP13G6.19% → 5.56%cut
2026-06-30Capital International Investors13G— → 6.10%holding filed in the new format
2026-03-31Cormorant Asset Management, LP13G6.35% → 6.19%cut
2025-12-31Cormorant Asset Management, LP13G6.70% → 6.35%cut
2025-12-31BlackRock, Inc.13G— → 5.03%new holding

Source: SEC, Schedules 13D and 13G, filed in a structured format since 18 December 2024; earlier filings are not read, so a holder that has not filed since then is not shown. 13D: the holder may seek to influence the company (activists, founders, strategic holders); it must amend within two business days of a change of 1% or more. 13G: the holder states it holds passively; it amends within 45 days after the quarter in which its holding changed materially, so a figure can be months old. The percentage is the filer's own, of the class of shares it names. Context only; not part of the score.

Institutional managers (SEC Form 13F)

Held on 2026-06-30
$2.1bn161 managers · 51.3M shares · 106.9% of the shares outstanding (SEC cover page, 2026-08-03)
Shares held, change on the quarter
−2.3%since 2026-03-31
Change on the year
+33.2%since 2025-06-30
Managers
29 new · 57 added · 46 cut · 15 sold out

The shares 13F managers held changed little on the quarter.

Source: SEC Form 13F, filed within 45 days of each quarter end by managers with $100 million or more in US-listed shares; long positions only (no short positions, options left out). Late filers of the quarter are not counted. A parent and a subsidiary can both report the same shares, so the total can count some twice. The quarter end (2026-06-30) and the insiders' purchases (last 2026-10-28) are different periods. Context only; not part of the score.

Regulatory filings

Unfold all 42 filings

Results and insider purchases

Results (8-K)Bought within 5 sessionsBought within 20 sessionsBuyers, 20 sessions before
2026-11-0407:12 ET · before the openNone1/5 sessions so farNone1/20 sessions so far7
2026-10-3017:12 ET · after the closeFirst session 2026-11-02None3/5 sessions so farNone3/20 sessions so far7
2026-08-0507:17 ET · before the openNoneNone0
2026-05-0707:15 ET · before the openNoneNone0

Results dates are the company's 8-K filings to the SEC under Item 2.02 (results of operations); one filed after the close counts from the next session. Purchases are open-market buys reported on Form 4 (code P), by trade date; a Form 4 can arrive two business days after the trade, so the latest days can still fill in. Facts only; this does not change the score or rank.

Ownership and trading-plan context

Direct / indirect ownershipDirect, Indirect, Mixed direct / indirect
10b5-1 filing evidenceDeclared, Not declared in filing field
Evidence retrieved2026-11-05T23:55:35+00:00

These are accession-level filing fields. Unavailable means the evidence was not fetched or parsed; it is never inferred as “No” and does not adjust the US score.

Filing evidence

These are underlying national-feed records from the 365-day window ending on the saved ranking snapshot. The score uses only the latest 180 days; older qualifying equity purchases remain visible for audit but do not enter the current score. The original filer, role, transaction classification, instrument, price, volume, value and source fields are retained. The first three rows are shown; remaining records can be unfolded for audit. Other transaction types are retained but excluded from the score.

Excluded transactions & classification

7 qualifying purchase disclosure(s) · 11 transaction line(s)

Trade Oct 21, 2026Open market purchase
Ignelzi Troy A. · Chief Financial Officer
Published Oct 21, 2026 · Common Stock · 5500 shares × 26.1 USD · 143550.0 USD
Open filing
Trade Oct 22, 2026Open market purchase
MARAGANORE JOHN · Director
Published Oct 22, 2026 · Common Stock · 8239 shares × 26.3799 USD · 217343.9961 USD
Open filing
Trade Oct 22, 2026Open market purchase
MARAGANORE JOHN · Director
Published Oct 22, 2026 · Common Stock · 1172 shares × 26.9173 USD · 31547.0756 USD
Open filing
Unfold all 8 remaining filing row(s)
Transaction datePublishedFilerRoleTransactionInstrumentPrice (local currency)Quote currencyVolumeReported value (local currency)Source
2026-10-222026-10-22PAUL STEVEN MDirectorOpen market purchaseCommon Stock27.28 USDUSD35714974277.92 USDOpen filing
2026-10-222026-10-22Young Wendy B.DirectorOpen market purchaseCommon Stock26.39 USDUSD378999991.71 USDOpen filing
2026-10-222026-10-22Silva Paul MDirectorOpen market purchaseCommon Stock27.075 USDUSD368099636.0 USDOpen filing
2026-10-232026-10-23Sanchez RamiroDirectorOpen market purchaseCommon Stock27.3549 USDUSD360098477.64 USDOpen filing
2026-10-282026-10-30HEALY JAMESDirectorOpen market purchaseCommon Stock21.0 USDUSD95238019999980.0 USDOpen filing
2026-10-282026-10-30HEALY JAMESDirectorOpen market purchaseCommon Stock21.0 USDUSD6395134295.0 USDOpen filing
2026-10-282026-10-30HEALY JAMESDirectorOpen market purchaseCommon Stock21.0 USDUSD377279212.0 USDOpen filing
2026-10-282026-10-30HEALY JAMESDirectorOpen market purchaseCommon Stock21.0 USDUSD6933145593.0 USDOpen filing

Showing 11 of 11 matching raw-feed row(s) from the current 365-day research window. Prices and reported values remain in the filing currency and its major unit (for example, UK pence are parsed as GBP). The screen-level $ aggregate is separately FX-normalised for research ranking, not a trade-date conversion.

Other disclosed transactions · excluded from score

View 78 other transaction(s)

Trade Dec 17, 2025Open market sale
Ceesay Abraham · Chief Executive Officer
Published Dec 18, 2025 · Common Stock · 2792.0 shares × 30.04 USD · 83871.68 USD
Open filing
Trade Dec 17, 2025Open market sale
Ceesay Abraham · Chief Executive Officer
Published Dec 18, 2025 · Common Stock · 515.0 shares × 31.04 USD · 15985.6 USD
Open filing
Trade Dec 17, 2025Open market sale
Ceesay Abraham · Chief Executive Officer
Published Dec 18, 2025 · Common Stock · 2421.0 shares × 30.04 USD · 72726.84 USD
Open filing
Unfold all 75 remaining filing row(s)
Transaction datePublishedFilerRoleTransactionInstrumentPrice (local currency)Quote currencyVolumeReported value (local currency)Source
2025-12-172025-12-18Ceesay AbrahamChief Executive OfficerOpen market saleCommon Stock28.84 USDUSD2441.070398.44 USDOpen filing
2025-12-172025-12-18Ceesay AbrahamChief Executive OfficerOpen market saleCommon Stock31.04 USDUSD600.018624.0 USDOpen filing
2025-12-172025-12-18Ceesay AbrahamChief Executive OfficerOpen market saleCommon Stock28.84 USDUSD2147.061919.48 USDOpen filing
2025-12-152025-12-16Bredt DavidChief Scientific OfficerOpen market saleCommon Stock29.95 USDUSD7704.0230734.8 USDOpen filing
2025-12-152025-12-16Bredt DavidChief Scientific OfficerOpen market saleCommon Stock30.68 USDUSD796.024421.28 USDOpen filing
2025-11-262025-12-01Gault CherylChief Operating OfficerExercise of derivative securityCommon Stock1.8 USDUSD5000.09000.0 USDOpen filing
2025-11-262025-12-01Gault CherylChief Operating OfficerOpen market saleCommon Stock30.1 USDUSD5000.0150500.0 USDOpen filing
2025-11-172025-11-18Ceesay AbrahamChief Executive OfficerOpen market saleCommon Stock24.91 USDUSD2242.055848.22 USDOpen filing
2025-11-172025-11-18Ceesay AbrahamChief Executive OfficerOpen market saleCommon Stock25.43 USDUSD3056.077714.08 USDOpen filing
2025-11-172025-11-18Ceesay AbrahamChief Executive OfficerOpen market saleCommon Stock24.92 USDUSD2777.069202.84000000001 USDOpen filing
2025-11-172025-11-18Ceesay AbrahamChief Executive OfficerOpen market saleCommon Stock25.44 USDUSD2841.072275.04000000001 USDOpen filing
2025-11-172025-11-18Bredt DavidChief Scientific OfficerOpen market saleCommon Stock25.39 USDUSD5344.0135684.16 USDOpen filing
2025-11-172025-11-18Bredt DavidChief Scientific OfficerOpen market saleCommon Stock24.84 USDUSD3156.078395.04 USDOpen filing
2026-03-302026-03-31Gault CherylChief Operating OfficerOpen market saleCommon Stock28.04 USDUSD7161.0200794.44 USDOpen filing
2026-03-302026-03-31Gault CherylChief Operating OfficerOpen market saleCommon Stock28.55 USDUSD2839.081053.45 USDOpen filing
2026-03-252026-03-26Yeleswaram KrishnaswamyChief Development OfficerOpen market saleCommon Stock29.99 USDUSD10115.0303348.85 USDOpen filing
2026-03-052026-03-09Gault CherylChief Operating OfficerOpen market saleCommon Stock28.93 USDUSD2014.058265.02 USDOpen filing
2026-02-192026-02-19Bredt DavidChief Scientific OfficerExercise of derivative securityCommon Stock1.8 USDUSD6000.010800.0 USDOpen filing
2026-02-182026-02-19Ceesay AbrahamChief Executive OfficerOpen market saleCommon Stock29.05 USDUSD3552.0103185.6 USDOpen filing
2026-02-182026-02-19Ceesay AbrahamChief Executive OfficerOpen market saleCommon Stock29.8 USDUSD2100.062580.0 USDOpen filing
2026-02-182026-02-19Ceesay AbrahamChief Executive OfficerOpen market saleCommon Stock29.04 USDUSD2983.086626.31999999999 USDOpen filing
2026-02-182026-02-19Ceesay AbrahamChief Executive OfficerOpen market saleCommon Stock29.8 USDUSD2281.067973.8 USDOpen filing
2026-02-172026-02-19Bredt DavidChief Scientific OfficerOpen market saleCommon Stock29.59 USDUSD2200.065098.0 USDOpen filing
2026-02-172026-02-19Bredt DavidChief Scientific OfficerOpen market saleCommon Stock28.95 USDUSD5400.0156330.0 USDOpen filing
2026-02-172026-02-19Bredt DavidChief Scientific OfficerOpen market saleCommon Stock28.02 USDUSD900.025218.0 USDOpen filing
2026-01-202026-01-22Ceesay AbrahamChief Executive OfficerOpen market saleCommon Stock26.11 USDUSD5083.0132717.13 USDOpen filing
2026-01-202026-01-22Ceesay AbrahamChief Executive OfficerOpen market saleCommon Stock26.12 USDUSD5833.0152357.96 USDOpen filing
2026-01-152026-01-16Bredt DavidChief Scientific OfficerOpen market saleCommon Stock26.83 USDUSD8300.0222689.0 USDOpen filing
2026-01-152026-01-16Bredt DavidChief Scientific OfficerOpen market saleCommon Stock27.4 USDUSD200.05480.0 USDOpen filing
2025-12-312026-01-05Bredt DavidChief Scientific OfficerOpen market saleCommon Stock30.05 USDUSD6567.0197338.35 USDOpen filing
2025-12-312026-01-05Bredt DavidChief Scientific OfficerGrant or awardCommon Stock—USD18000.00.0 USDOpen filing
2025-12-312026-01-05Yeleswaram KrishnaswamyChief Development OfficerGrant or awardCommon Stock—USD9000.00.0 USDOpen filing
2025-12-312026-01-05Yeleswaram KrishnaswamyChief Development OfficerOpen market saleCommon Stock30.05 USDUSD2840.085342.0 USDOpen filing
2026-05-262026-05-28TRV GP V, LLC; TRV GP VI, LLC; Third Rock Ventures GP V, LP; Third Rock Ventures GP VI, L.P.; Third Rock Ventures V, L.P.; Third Rock Ventures VI, L.P.TenPercentOwnerOpen market saleCommon Stock40.05 USDUSD18572.0743808.6 USDOpen filing
2026-05-112026-05-13TRV GP V, LLC; TRV GP VI, LLC; Third Rock Ventures GP V, LP; Third Rock Ventures GP VI, L.P.; Third Rock Ventures V, L.P.; Third Rock Ventures VI, L.P.TenPercentOwnerOpen market saleCommon Stock40.24 USDUSD133618.05376788.32 USDOpen filing
2026-05-082026-05-11TRV GP V, LLC; TRV GP VI, LLC; Third Rock Ventures GP V, LP; Third Rock Ventures GP VI, L.P.; Third Rock Ventures V, L.P.; Third Rock Ventures VI, L.P.TenPercentOwnerOpen market saleCommon Stock40.31 USDUSD5018.0202275.58000000002 USDOpen filing
2026-05-072026-05-11TRV GP V, LLC; TRV GP VI, LLC; Third Rock Ventures GP V, LP; Third Rock Ventures GP VI, L.P.; Third Rock Ventures V, L.P.; Third Rock Ventures VI, L.P.TenPercentOwnerOpen market saleCommon Stock40.12 USDUSD271495.010892379.399999999 USDOpen filing
2026-04-172026-04-21TRV GP V, LLC; TRV GP VI, LLC; Third Rock Ventures GP V, LP; Third Rock Ventures GP VI, L.P.; Third Rock Ventures V, L.P.; Third Rock Ventures VI, L.P.TenPercentOwnerOpen market saleCommon Stock40.32 USDUSD426005.017176521.6 USDOpen filing
2026-04-172026-04-21Yeleswaram KrishnaswamyChief Development OfficerOpen market saleCommon Stock39.99 USDUSD20225.0808797.75 USDOpen filing
2026-04-142026-04-14Yeleswaram KrishnaswamyChief Development OfficerOpen market saleCommon Stock35.08 USDUSD10200.0357816.0 USDOpen filing
2026-04-132026-04-14Yeleswaram KrishnaswamyChief Development OfficerOpen market saleCommon Stock34.97 USDUSD9165.0320500.05 USDOpen filing
2026-04-102026-04-14Yeleswaram KrishnaswamyChief Development OfficerOpen market saleCommon Stock34.98 USDUSD500.017490.0 USDOpen filing
2026-04-082026-04-09Yeleswaram KrishnaswamyChief Development OfficerOpen market saleCommon Stock34.9 USDUSD360.012564.0 USDOpen filing
2026-09-232026-09-24Ceesay AbrahamChief Executive OfficerOpen market saleCommon Stock41.05 USDUSD43.01765.1499999999999 USDOpen filing
2026-09-232026-09-24Ceesay AbrahamChief Executive OfficerOpen market saleCommon Stock39.05 USDUSD1952.076225.59999999999 USDOpen filing
2026-09-232026-09-24Ceesay AbrahamChief Executive OfficerOpen market saleCommon Stock39.86 USDUSD215.08569.9 USDOpen filing
2026-09-082026-09-09Ceesay AbrahamChief Executive OfficerOpen market saleCommon Stock45.56 USDUSD7141.0325343.96 USDOpen filing
2026-09-082026-09-09Ceesay AbrahamChief Executive OfficerOpen market saleCommon Stock46.01 USDUSD1069.049184.689999999995 USDOpen filing
2026-08-252026-08-26Ceesay AbrahamChief Executive OfficerOpen market saleCommon Stock49.57 USDUSD18921.0937913.97 USDOpen filing
2026-08-252026-08-26Yeleswaram KrishnaswamyChief Development OfficerOpen market saleCommon Stock51.06 USDUSD16201.0827223.06 USDOpen filing
2026-08-252026-08-26Yeleswaram KrishnaswamyChief Development OfficerOpen market saleCommon Stock50.31 USDUSD20799.01046397.6900000001 USDOpen filing
2026-08-242026-08-26Yeleswaram KrishnaswamyChief Development OfficerOpen market saleCommon Stock50.0 USDUSD13160.0658000.0 USDOpen filing
2026-08-192026-08-20Yeleswaram KrishnaswamyChief Development OfficerOpen market saleCommon Stock49.9 USDUSD404.020159.6 USDOpen filing
2026-08-112026-08-12Ceesay AbrahamChief Executive OfficerOpen market saleCommon Stock46.9 USDUSD3664.0171841.6 USDOpen filing
2026-08-112026-08-12Ceesay AbrahamChief Executive OfficerOpen market saleCommon Stock48.04 USDUSD19500.0936780.0 USDOpen filing
2026-08-112026-08-12Ceesay AbrahamChief Executive OfficerOpen market saleCommon Stock48.62 USDUSD5794.0281704.27999999997 USDOpen filing
2026-08-102026-08-12Ceesay AbrahamChief Executive OfficerOpen market saleCommon Stock45.97 USDUSD14171.0651440.87 USDOpen filing
2026-08-102026-08-12Ceesay AbrahamChief Executive OfficerOpen market saleCommon Stock46.75 USDUSD8370.0391297.5 USDOpen filing
2026-07-272026-07-29Ceesay AbrahamChief Executive OfficerOpen market saleCommon Stock42.11 USDUSD2203.092768.33 USDOpen filing
2026-07-272026-07-29Ceesay AbrahamChief Executive OfficerOpen market saleCommon Stock42.74 USDUSD7.0299.18 USDOpen filing
2026-07-142026-07-15Ceesay AbrahamChief Executive OfficerOpen market saleCommon Stock40.57 USDUSD2729.0110715.53 USDOpen filing
2026-07-142026-07-15Ceesay AbrahamChief Executive OfficerOpen market saleCommon Stock39.72 USDUSD5481.0217705.32 USDOpen filing
2026-06-302026-07-01Gault CherylChief Operating OfficerOpen market saleCommon Stock43.15 USDUSD1000.043150.0 USDOpen filing
2026-06-302026-07-01Gault CherylChief Operating OfficerOpen market saleCommon Stock42.17 USDUSD3308.0139498.36000000002 USDOpen filing
2026-06-302026-07-01Gault CherylChief Operating OfficerOpen market saleCommon Stock40.09 USDUSD1900.076171.0 USDOpen filing
2026-06-302026-07-01Gault CherylChief Operating OfficerOpen market saleCommon Stock41.39 USDUSD3792.0156950.88 USDOpen filing
2026-06-292026-07-01Ceesay AbrahamChief Executive OfficerOpen market saleCommon Stock40.34 USDUSD876.035337.840000000004 USDOpen filing
2026-06-292026-07-01Ceesay AbrahamChief Executive OfficerOpen market saleCommon Stock39.77 USDUSD7344.0292070.88 USDOpen filing
2026-09-302026-10-01Gault CherylChief Operating OfficerOpen market saleCommon Stock33.0364 USDUSD7925261813.47 USDOpen filing
2026-09-302026-10-01Gault CherylChief Operating OfficerOpen market saleCommon Stock33.7556 USDUSD207570042.87 USDOpen filing
2026-10-072026-10-08Ceesay AbrahamChief Executive OfficerOpen market saleCommon Stock30.66 USDUSD114735167.02 USDOpen filing
2026-10-062026-10-08Ceesay AbrahamChief Executive OfficerOpen market saleCommon Stock32.0314 USDUSD3375108105.97499999999 USDOpen filing
2026-10-212026-10-23Ceesay AbrahamChief Executive OfficerOpen market saleCommon Stock29.1618 USDUSD221064447.578 USDOpen filing
2026-10-302026-11-03TRV GP V, LLC; TRV GP VI, LLC; Third Rock Ventures GP V, LP; Third Rock Ventures GP VI, L.P.; Third Rock Ventures V, L.P.; Third Rock Ventures VI, L.P.Director,TenPercentOwnerGrant or awardCommon Stock21.0 USDUSD2380954999995.0 USDOpen filing
2026-10-302026-11-03TRV GP V, LLC; TRV GP VI, LLC; Third Rock Ventures GP V, LP; Third Rock Ventures GP VI, L.P.; Third Rock Ventures V, L.P.; Third Rock Ventures VI, L.P.Director,TenPercentOwnerGrant or awardCommon Stock21.0 USDUSD119047624999996.0 USDOpen filing

Showing 78 of 78 matching raw-feed row(s) from the current 365-day research window. Prices and reported values remain in the filing currency and its major unit (for example, UK pence are parsed as GBP). The screen-level $ aggregate is separately FX-normalised for research ranking, not a trade-date conversion.

Model & Sources

Signal history

84.7 / 100

Latest recorded score

↓ -0.1 ptssince the first recorded snapshot on 2026-11-04; 1 calendar days observed
Recorded snapshots
2
First snapshot
2026-11-04

There is not yet a 30-calendar-day comparison; earlier scores are not reconstructed. These are raw signal scores saved when each full scoring run completed. They describe changes in research ranking, not price performance or returns.

Why did it change?

Less than 30 days of comparable history is available, so factor movement is not yet decomposed.

Signal score history

Fixed 0–100 scale; dates are spaced by calendar time.

02550751002026-11-04 · 84.82026-11-05 · 84.7Nov 04Nov 05

Recent recorded points

  1. 84.8
  2. 84.7
View all recorded scores
Snapshot dateSignal score
2026-11-0484.8
2026-11-0584.7
Why this score? · Model details

Priority = 100 × Σ(fixed weight × 0–1 rule-based input)

FactorWeightThis company inputPoint contribution
15-day buyer breadth (count)35%1.00035.0
Qualified-buy size25%0.89722.4
Role informativeness (inverted)20%0.75015.0
Recency10%0.8758.8
Buy/sell conviction10%0.3553.5

This is a heuristic ordering under the current rules, not a calibrated return forecast. It explains why candidates rank differently; the public-filing evidence and data limits are shown below.

Snapshot & identity

Snapshot date
2026-11-05
Ticker
RAPP
ISIN
—
Sector
Healthcare
Industry
—

Company logos by Parqet

How to read Form 4 transaction codes

CodeInterpretationScreen treatment
POpen-market / private purchaseBuy evidence when the security is qualifying equity
SSaleSell evidence when the security is qualifying equity
AGrant / awardContext only
FTax-related withholdingContext only
MOption exerciseContext only
GGiftContext only
J / LOther / non-directionalContext only

P/S rows for options, warrants, compensation units and debt remain visible for audit but are excluded from equity scores and quotes.